VCA Stocks

Koronis Raises $20M in Series D Funding Koronis said the money will help pay for proof-of-concept studies for a prospective HIV treatment that employs a novel technology called Viral Decay Acceleration. Koronis said the treatment, called KP-1461, has already begun its Phase 2a trials and should finish its testing by some time next year.